文献速递骨肿瘤创伤骨科

接受肿瘤治疗假体植入患者的 Surgical Site Infection:患者、疾病及索引手术因素评估

Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
PubMed 文献 · J Bone Joint Surg Am · 2023-07-19

该研究基于PARITY数据集,分析96例下肢原发骨肿瘤节段性假体重建后发生手术部位感染(SSI)的患者,27例(28%)感染根除成功,69例治疗失败。多变量模型显示,肿瘤切除时筋膜切除是与SSI治疗结局显著相关的唯一变量(OR=10.21,95%CI 2.65-46.21,p=0.018)。

要点

  • 96例SSI患者中,27例(28%)感染根除成功,69例治疗失败。
  • 肿瘤切除时筋膜切除与SSI治疗失败显著相关(OR=10.21,95%CI 2.65-46.21,p=0.018)。
  • 局部肌肉/皮肤移植及深部Hemovac使用在单变量分析中与SSI治疗结局显著相关。

核心结论

  • 该PARITY试验数据的二次分析结果进一步揭示了患者、疾病及治疗特异性因素与SSI治疗结局的关联,可能有助于为因肿瘤指征行股骨或胫骨节段性骨重建后发生SSI的患者提供决策和管理信息。

研究设计与样本

  • 本研究为使用Prophylactic Antibiotic Regimens in Tumor Surgery(PARITY)数据集的二次分析,纳入下肢原发骨肿瘤节段性假体重建后诊断为SSI的患者96例。
  • 主要结局为二分类变量:感染治疗成功或失败;失败定义为无法根除感染,即截肢或保留肢体但需慢性抗生素抑制(>90天或研究结束时仍在治疗)。
  • 针对手术特征、癌症治疗相关特征及肿瘤特征分别建立多变量模型,多变量检验纳入基于已知感染关联或单变量检验结果选择的变量。

主要发现

  • 96例SSI患者中,27例(28%)感染根除成功,69例治疗失败。
  • 与SSI治疗结局显著相关的基线和索引手术变量包括:筋膜切除量中等/较大≥1 cm²(OR=10.21,95%CI 2.65-46.21,p=0.001)、使用局部肌肉/皮肤移植(OR=11.88,95%CI 1.83-245.83,p=0.031)、使用深部Hemovac(OR=0.24,95%CI 0.05-0.85,p=0.041)。
  • 最终多变量模型中,原发肿瘤切除时筋膜切除是与治疗结局显著相关的唯一变量(OR=10.21,95%CI 2.65-46.21,p=0.018)。

局限性

  • 证据等级为预后III级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical site infection (SSI) after segmental endoprosthetic reconstruction in patients treated for oncologic conditions remains both a devastating and a common complication. The goal of the present study was to identify variables associated with the success or failure of treatment of early SSI following the treatment of a primary bone tumor with use of a segmental endoprosthesis. METHODS: The present study used the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) data set to identify patients who had been diagnosed with an SSI after undergoing endoprosthetic reconstruction of a lower extremity primary bone tumor. The primary outcome of interest in the present study was a dichotomous variable: the success or failure of infection treatment. We defined failure as the inability to eradicate the infection, which we considered as an outcome of amputation or limb retention with chronic antibiotic suppression (>90 days or ongoing therapy at the conclusion of the study). Multivariable models were created with covariates of interest for each of the following: surgery characteristics, cancer treatment-related characteristics, and tumor characteristics. Multivariable testing included variables selected on the basis of known associations with infection or results of the univariable tests. RESULTS: Of the 96 patients who were diagnosed with an SSI, 27 (28%) had successful eradication of the infection and 69 had treatment failure. Baseline and index procedure variables showing significant association with SSI treatment outcome were moderate/large amounts of fascial excision ≥1 cm2) (OR, 10.21 [95% CI, 2.65 to 46.21]; p = 0.001), use of local muscle/skin graft (OR,11.88 [95% CI, 1.83 to 245.83]; p = 0.031), and use of a deep Hemovac (OR, 0.24 [95% CI, 0.05 to 0.85]; p = 0.041). In the final multivariable model, excision of fascia during primary tumor resection was the only variable with a significant association with treatment outcome (OR, 10.21 [95% CI, 2.65 to 46.21]; p = 0.018). CONCLUSIONS: The results of this secondary analysis of the PARITY trial data provide further insight into the patient-, disease-, and treatment-specific associations with SSI treatment outcomes, which may help to inform decision-making and management of SSI in patients who have undergone segmental bone reconstruction of the femur or tibia for oncologic indications. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Ray GS, Werth P, Alexander JH, et al. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors. J Bone Joint Surg Am. 2023. PMID: 37466585. doi:10.2106/JBJS.22.01376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。